trending Market Intelligence /marketintelligence/en/news-insights/trending/YkwUcMlsuoUq0IkSlnRC_g2 content esgSubNav
In This List

Resverlogix closes C$87M placement with Shenzhen Hepalink

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Resverlogix closes C$87M placement with Shenzhen Hepalink

Resverlogix Corp. closed its private placement of 60,416,667 equity units to Shenzhen Hepalink Pharmaceutical Group Co. Ltd. priced at C$1.44 per unit for gross proceeds of C$87 million.

Each unit comprises 1 common share and 0.082759 of a common share purchase warrant. Each full warrant will be exercisable at a price of C$1.64 per share for a period of four years from the offering's closing.

The company plans to use the net proceeds to repay its C$68.8 million secured loan, which matures Dec. 26.